External resources

Urgent, Coordinated Global Action on Lung Cancer (2022)

A white paper authored by the Lung Cancer Collaboration, which is a partnership between the Lung Ambition Alliance and the World Economic Forum. It makes several recommendations for governments to target lung cancer and invest in the condition, with the aim of driving early diagnosis and improving treatment and care to increase people’s chances of survival.

Learning Lessons from across Europe: Prioritizing Lung Cancer after COVID-19 (2022)

This report has been developed by the World Economic Forum and the Lung Ambition Alliance. It shares the lessons learnt from COVID-19, looking at how the pandemic has impacted lung cancer care in different countries across Europe. The report also aims to guide long-term care for people with lung cancer.

Lung cancer screening: the cost of inaction (2021)

This report presents the case for investing in comprehensive lung cancer screening programmes based on a review of international literature, including implementation research from several countries. It considers the public health and economic benefits of earlier detection of lung cancer and sets out key factors in the successful implementation of a targeted screening programme.

Lung cancer screening: the cost of inaction infographic (2021)

This infographic highlights how investing in lung cancer screening would have a significant public health and economic impact on our society.

Lung cancer screening: building resilience and sustainability of healthcare systems (2021)

The Health Policy Partnership developed a case study on lung cancer screening in response to an invitation from the Partnership for Health System Sustainability and Resilience (PHSSR). The report looks at early detection, with a focus on screening, and how it can aid countries’ efforts to build resilient and sustainable health systems. The Lung Ambition Alliance and the International Association for the Study of Lung Cancer (IASLC) endorsed the case study.

Lung Ambition Alliance open letter (2021)

The Lung Ambition Alliance wrote an open letter to the members of the European Special Committee on Beating Cancer (BECA) in October 2021, urging them to prioritise lung cancer screening in the European Union.

Implementation Guide for Lung Cancer Screening (2018)

A comprehensive resource developed by the American Thoracic Society and American Lung Association to provide practical guidance on how to implement lung cancer screening. The report is also presented as a digital resource with dedicated web pages for each section.

Improving cancer screening in the European Union (2022)

This report from the Science Advice for Policy by European Academies (SAPEA) explores the underlying principles, governance and feasibility of organised cancer screening programmes, and how existing programmes for breast, colorectal and cervical cancer could be improved in the European Union.

Report on the Lung Cancer Screening Enquiry (2020)

Cancer Australia’s report outlines the findings of an enquiry into a national lung cancer screening programme, including national and international evidence on lung cancer screening, the best design for a screening programme within the Australian health policy context and the mechanics of how a lung cancer screening programme could be effectively delivered in Australia.

The Canadian Partnership Against Cancer’s business case and readiness assessment toolkit for lung cancer screening (2020)

The Canadian Partnership Against Cancer has developed a business case for jurisdictions to adapt and use in their own provincial or territorial contexts to advance lung cancer screening in Canada. A readiness assessment toolkit has also been created as a complementary resource to support partners in using the business case.

Reports from the United Kingdom Lung Cancer Coalition (multiple years)

The United Kingdom Lung Cancer Coalition (UKLCC) has published a selection of reports, including COVID-19 Matters and Early Diagnosis Matters.

Lung Cancer Won't Wait: Building resilience in lung cancer screening and diagnostics based on lessons from the pandemic (2021)

This report, developed by IQVIA, looks at how COVID-19 has affected lung cancer screening and diagnostic services around the world. It also considers some of the actions that have been taken to tackle the pandemic’s effects and the promise they hold for future efforts to address the burden of lung cancer.

Closing Gaps in Lung Cancer Screening: Connecting People, Communities, and Systems to Improve Equity and Access (2022)

In 2020–21, the President’s Cancer Panel held a series of meetings on cancer screening. This report is the culmination of those meetings, presenting four key goals for connecting people, communities, and systems to improve equity and access in cancer screening across the US and a series of recommendations for how to achieve them.

4th LuCE Report on Early Diagnosis and Screening in Lung Cancer (2019)

Lung Cancer Europe’s (LuCE’s) report focuses on early diagnosis and screening in lung cancer. Combining a literature review and a pan-European patient survey, this report highlights current challenges to receiving a fast and precise diagnosis. It also looks at challenges associated with analysing the current implementation of screening programmes across Europe. In addition, the report considers the patient perspective, particularly gaps in knowledge and educational needs in relation to receiving a diagnosis and undergoing screening.

ESR/ERS statement paper on lung cancer screening (2020)

This paper represents a narrative, non-systematic review of evidence from lung cancer screening trials and a description of the current practice of screening, as well as aspects that have not received adequate attention until now. It builds on a 2015 joint white paper on lung cancer screening from the European Society of Radiology (ESR) and European Respiratory Society (ERS).

Lung cancer LDCT screening and mortality reduction – evidence, pitfalls and future perspectives (2020)

This review focuses on the current evidence on lung cancer screening with low-dose computed tomography (LDCT) and discusses clinical developments in high-risk populations worldwide. The authors present a framework to define the scope of future implementation research on lung cancer screening programmes.

Lung screening benefits and challenges: a review of the data and outline for implementation (2021)

This literature review challenges concerns relating to computed tomographic lung cancer screening by evaluating its potential risks and benefits.

Lung cancer screening in Europe: where are we in 2021? (2021)

This paper reviews the recent evidence on lung cancer screening with low-dose computed tomography, focusing on the issues associated with its implementation across Europe.

Lung cancer screening implementation: complexities and priorities (2020)

This review considers critical points along the patient journey, identifying barriers to smoker engagement in lung and other cancer screening programmes, recruitment strategies used in trials and clinical programmes, and associated screening uptake. The authors propose a standardised nomenclature for recording and calculating recruitment outcomes.

Contemporary issues in the implementation of lung cancer screening (2021)

This review focuses on selected contemporary issues in the path to implementing cost-effective lung cancer screening at the population level. The future impact of emerging technologies, such as deep learning and biomarkers, is also discussed.

Landscape on CT screening for lung cancer in Asia (2019)

This paper reviews lung cancer incidence, mortality, aetiology and smoking in Asia. It also looks at systematic reviews on computed tomography (CT) lung cancer screening studies, including ongoing projects and recommendations on lung cancer screening in Asia.

Implementation planning for lung cancer screening in China (2019)

This paper examines the requirements for the implementation of organised lung cancer screening in China, including a review of ongoing feasibility studies.

Global Lung Cancer Coalition Global Lung Cancer Atlas

The Global Lung Cancer Coalition (GLCC) interactive atlas is a comprehensive resource for lung cancer statistics. Users can access data on lung cancer incidence, mortality, survival and national policy for countries around the world. The GLCC has also produced a learning module on the early detection of lung cancer as part of its atlas.

The International Cancer Control Partnership Portal

The International Cancer Control Partnership (ICCP) is a group of organisations engaged in cancer control planning efforts. The ICCP Portal is a hub for global resources, with toolkits, news, national cancer control plans and more.

The Video Journal of Oncology Lung Channel

The Video Journal of Oncology (VJOncology) Lung Channel is a series of recordings from interviews, round-table discussions, podcasts and conference coverage. Its focus is on sharing updates in lung cancer and mesothelioma research, including treatment and screening.

eCancer channel

The journal eCancer archives recordings of feature interviews, panel discussions and conference coverage on almost every topic in oncology, including lung cancer.

Lung Cancer Atlas (US)

The National Lung Cancer Roundtable and the American Cancer Society has produced a US-focused interactive atlas with multiple interfaces, including state-level information and survivor stories, and a health system focused dashboard.

Lung Cancer Screening Locator Tool (US)

An interactive map developed by the American College of Radiology (ACR). It offers a searchable interface of over 4,000 lung cancer screening centres in the US, including ACR-designated centres (sites that exceed requirements for basic equipment, personnel and imaging performance).

OncoSim (Canada)

The Canadian Partnership Against Cancer’s OncoSim model is a free, web-based simulation tool that evaluates cancer control strategies. Combining data from the real world, expert opinion and published literature, OncoSim projects health and economic outcomes and attributes them to 27 risk factors, such as smoking and low physical activity. It currently models four cancer sites (breast, colorectal, lung and cervical) and related screening programmes in detail, and provides high-level projections for 28 other cancer sites.